Amyloid Reducing Drugs
Newly Approved Drugs for Mild Alzheimer's
Aduhelm Updates
Approval Announcements:
Alzheimer's Association and opinion of final decision
Center for Medicare and Medicaid Services (CMS)-coverage decision
Consent Guidelines for Treatment
American Academy of Neurology-aducanumab
Opinions from AGREEDementia Members
Developing an Economic and Policy Research Agenda for Blood Biomarkers of Neurodegenerative Diseases
The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA